A detailed history of North Rock Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, North Rock Partners, LLC holds 18,386 shares of MRK stock, worth $1.82 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
18,386
Previous 26,894 31.64%
Holding current value
$1.82 Million
Previous $3.33 Million 37.31%
% of portfolio
0.18%
Previous 0.29%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$111.15 - $128.97 $945,664 - $1.1 Million
-8,508 Reduced 31.64%
18,386 $2.09 Million
Q2 2024

Aug 06, 2024

SELL
$123.8 - $132.96 $569,603 - $611,748
-4,601 Reduced 14.61%
26,894 $3.33 Million
Q1 2024

May 07, 2024

BUY
$113.24 - $131.95 $776,260 - $904,517
6,855 Added 27.82%
31,495 $4.16 Million
Q4 2023

Feb 08, 2024

SELL
$100.18 - $109.02 $144,058 - $156,770
-1,438 Reduced 5.51%
24,640 $2.69 Million
Q3 2023

Oct 24, 2023

BUY
$102.95 - $114.33 $488,806 - $542,838
4,748 Added 22.26%
26,078 $2.68 Million
Q2 2023

Aug 02, 2023

BUY
$108.61 - $118.38 $119,253 - $129,981
1,098 Added 5.43%
21,330 $2.46 Million
Q1 2023

May 03, 2023

SELL
$102.94 - $114.86 $46,631 - $52,031
-453 Reduced 2.19%
20,232 $2.15 Million
Q4 2022

Feb 01, 2023

SELL
$87.44 - $112.11 $30,341 - $38,902
-347 Reduced 1.65%
20,685 $2.29 Million
Q3 2022

Nov 02, 2022

BUY
$84.53 - $94.96 $60,777 - $68,276
719 Added 3.54%
21,032 $1.81 Million
Q2 2022

Aug 04, 2022

BUY
$83.49 - $94.64 $48,006 - $54,418
575 Added 2.91%
20,313 $1.85 Million
Q1 2022

May 05, 2022

BUY
$73.51 - $82.4 $126,290 - $141,563
1,718 Added 9.53%
19,738 $1.62 Million
Q4 2021

Feb 07, 2022

SELL
$72.28 - $90.54 $552,652 - $692,268
-7,646 Reduced 29.79%
18,020 $1.38 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $163,143 - $179,417
2,276 Added 9.73%
25,666 $1.93 Million
Q2 2021

Aug 12, 2021

BUY
$70.31 - $77.77 $55,052 - $60,893
783 Added 3.46%
23,390 $1.82 Million
Q1 2021

May 11, 2021

BUY
$68.86 - $81.11 $442,976 - $521,780
6,433 Added 39.77%
22,607 $1.74 Million
Q4 2020

Feb 08, 2021

SELL
$71.77 - $79.65 $24,186 - $26,842
-337 Reduced 2.04%
16,174 $1.32 Million
Q3 2020

Nov 12, 2020

BUY
$73.18 - $82.95 $578,048 - $655,222
7,899 Added 91.72%
16,511 $1.37 Million
Q2 2020

Aug 13, 2020

BUY
$70.42 - $80.13 $70 - $80
1 Added 0.01%
8,612 $666,000
Q2 2020

Aug 11, 2020

BUY
$70.42 - $80.13 $146,332 - $166,510
2,078 Added 31.81%
8,611 $666,000
Q1 2020

May 13, 2020

SELL
$63.36 - $87.82 $149,656 - $207,430
-2,362 Reduced 26.55%
6,533 $503,000
Q4 2019

Feb 12, 2020

BUY
$77.58 - $87.54 $1.38 Million - $1.55 Million
17,736 Added 236.26%
25,243 $809,000
Q4 2019

Feb 12, 2020

SELL
$77.58 - $87.54 $1.27 Million - $1.43 Million
-16,348 Reduced 64.76%
8,895 $809,000
Q3 2019

Nov 12, 2019

BUY
$76.08 - $82.93 $299,298 - $326,246
3,934 Added 110.1%
7,507 $636,000
Q2 2019

Aug 12, 2019

BUY
$69.84 - $81.59 $4,539 - $5,303
65 Added 1.85%
3,573 $301,000
Q1 2019

May 14, 2019

SELL
$69.58 - $79.36 $3,757 - $4,285
-54 Reduced 1.52%
3,508 $293,000
Q4 2018

Feb 13, 2019

BUY
$65.24 - $75.71 $22,899 - $26,574
351 Added 10.93%
3,562 $277,000
Q3 2018

Nov 13, 2018

BUY
$57.69 - $67.84 $185,242 - $217,834
3,211 New
3,211 $230,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track North Rock Partners, LLC Portfolio

Follow North Rock Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Rock Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Rock Partners, LLC with notifications on news.